GX Acquisition Corp.

Status: Deal Closed
U=S+W/2 W=S@11.5
IPO Proceeds, $M $287.50M
IPO Date May 21, 2019
CEO Jay R. Bloom; Dean C. Kehler
Left Lead Cantor Fitzgerald
IPO Cash in Trust 100.0%
SPAC Tenor 24+2
IPO Sector General

Not specified

IPO Geography Global
Target Company Celularity
Deal Announced Jan 8, 2021
Deal Size, $M $1,293.00M
Deal Sector Healthcare
Deal Geography US/Canada
SEC Filings www.sec.gov
Approval Vote Jul 14, 2021
Amendment Vote TBD
Closing Date Jul 16, 2021
Formerly GXGX CELU CELUW

Sign up for Free Trial

No credit card required

Sign in for more on GX Acquisition Corp.:

  • Structure and cap table
  • 7 directors & officers
  • 28 filings and events
  • 1 underwriters
  • 7 deal advisors
  • 2 legal advisors
Structure

Sign in to view structure, cap table, and calendar of events.

Team
Name Age Title
Jay R. Bloom 63 Co-Chairman & CEO
Dean C. Kehler 62 Co-Chairman and CEO
Michael G. Maselli 59 VP of Acquisitions
Andrea J. Kellett 62 CFO
Hillel Weinberger 65 Director
Marc Mazur 59 Director
Paul S. Levy 71 Director

Sign in to view team biographies and more sponsor and affiliate data.

Advisors
Underwriters
Cantor Fitzgerald BR 25,000,000 units
25,000,000 units
Up-Front UW fee 2.00 %
Deferred UW fee 3.50 %

Sign in to view more advisor data.

Deal

Sign in to view merger details and deal financials.

Filings

Sign in to view 28 filings.

Shareholders

Sign in to view shareholders 13F filing data.